This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

BioTalk

Powered by Bird & Bird

| less than a minute read

An international overview of the regulatory legislation concerning telemedicine

Telemedicine has been available to healthcare providers for several years. However, it was not until quite recently that the field of telemedicine really took off due to the rise of the COVID-19 pandemic. With the new standard of social distancing and the burden on the healthcare system, the COVID-19 pandemic forced rapid implementation of telemedicine in day-to-day practice, resulting in the use of technology to provide healthcare growing significantly.

This overview is intended to summarise the national developments and legal frameworks with regard to telemedicine in order assist our clients in understanding their position. This document does not constitute legal advice, if you require more information please feel free to reach out to the country contacts in this document.

Read the full document here

Authored by By Katrina Dang, Johanna Harelimana, Christian LindenthalHester BorgersEmma Stok, Enrique Rivas, Pieter ErasmusPatrick Brown

Tags

digital health, ehealth, healthcare, life sciences, mhealth, pharmaceuticals, telemedicine, biotech, medtech, regulatory